Syngene International Q2 Results 2023 

Read this story to learn about Q2- highlights, performance, earnings, dividend updates, market performance, etc., Syngene Share Price

Q2 2023-24: Strong Growth

[{"selector":"#anim-d8c1bd7c-c861-458c-9f76-17eb46001978","keyframes":{"opacity":[0,1]},"delay":250,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-51581352-0be6-48d4-b6dc-dc256d931597","keyframes":{"opacity":[0,1]},"delay":800,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-491a4a9b-49d7-4d19-9d91-a90946ca2c1d","keyframes":{"transform":["translate3d(0px, 303.41878%, 0)","translate3d(0px, 0px, 0)"]},"delay":800,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Operational revenue surges by 18.5%, showcasing robust Q2 performance. Syngene Share Price

Profit After Tax Spikes

[{"selector":"#anim-c2e0ff09-1811-4ad9-a89c-f60e715763cf","keyframes":{"opacity":[0,1]},"delay":250,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-1e30eb39-0a36-430d-adaa-2ca8aac21001","keyframes":{"opacity":[0,1]},"delay":800,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-d431857b-336a-4879-a4f0-d5348af4abf4","keyframes":{"transform":["translate3d(0px, 572.60967%, 0)","translate3d(0px, 0px, 0)"]},"delay":800,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] PAT before exceptional items jumped by an impressive 20% in Q2. Syngene Share Price

[{"selector":"#anim-4db8ea24-163f-41c5-bc63-a6abd503e4ac","keyframes":{"opacity":[0,1]},"delay":250,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-2601434a-8ffc-4842-90ea-9924debb35d0","keyframes":{"opacity":[0,1]},"delay":800,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-9f4c2ba3-b70b-4c7d-9167-ea19a7ff651f","keyframes":{"transform":["translate3d(0px, 752.23648%, 0)","translate3d(0px, 0px, 0)"]},"delay":800,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Development & Manufacturing Shine, R&D Boost Strategic partnerships drive growth in these key service areas. Dedicated research and development services contribute to positive Q2 trends. Learn more

Strategic Deals Propel Growth

[{"selector":"#anim-1c1727d2-e4a7-493a-8743-a8c9712b483e","keyframes":{"opacity":[0,1]},"delay":250,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-bed825e2-970b-4eea-a585-1f8692a9fcac","keyframes":{"opacity":[0,1]},"delay":800,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-48ff5a80-13b1-4d1b-a06c-9aec2e3c3da9","keyframes":{"transform":["translate3d(0px, 256.68725%, 0)","translate3d(0px, 0px, 0)"]},"delay":800,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Collaborations with Zoetis and Stelis Biopharma mark significant progress. Acquisition of land and FDA authorization further strengthens Syngene's position. Learn more